Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Hurley

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancerJudith Hurley, Philomena Doliny, Isildinha Reis, et al.
Journal of Psychosomatic Research|July 17, 2004
Breast cancer patients have improved immune and neuroendocrine functions following massage therapyMaria Hernandez-Reif, Gail Ironson, Tiffany Field, et al.
Molecular Genetics & Genomic Medicine|December 22, 2017
Short report: Follow-up of Bahamian women with a BRCA1 or BRCA2 mutationSteven A Narod, Raleigh Butler, David Bobrowski, et al.
Journal of Global Oncology|July 19, 2017
Development of a Breast Cancer Treatment Program in Port-au-Prince, Haiti: Experiences From the FieldVincent DeGennaro, Rachel Libby, Elizabeth Patberg, et al.
Breast Cancer Research and Treatment|February 15, 2017
A high frequency of PALB2 mutations in Jamaican patients with breast cancerJordan Lerner-Ellis, Talia Donenberg, Humayun Ahmed, et al.
Clinical Breast Cancer|July 16, 2008
A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancerOrlando Silva, Gilberto Lopes, Daniel Morgenzstern, et al.
JAMA Network Open|December 5, 2023
Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIVDaniel S O'Neil, Yehoda M Martei, Katherine D Crew, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Pain education for underserved minority cancer patients: a randomized controlled trialKaren O Anderson, Tito R Mendoza, Richard Payne, et al.
Breast Cancer Research and Treatment|June 30, 2010
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancerChristopher Lobo, Gilberto Lopes, Odalys Baez, et al.
Lancet Regional Health. Americas|November 19, 2025
Differences in breast cancer outcomes amongst Caribbean born women in Florida, USA-a population-based analysisAlex P Sanchez-Covarrubias, Priscila Barreto-Coelho, Jovanka Ravix, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancerJudith Hurley, Philomena Doliny, Isildinha Reis, et al.
Journal of Psychosomatic Research|July 17, 2004
Breast cancer patients have improved immune and neuroendocrine functions following massage therapyMaria Hernandez-Reif, Gail Ironson, Tiffany Field, et al.
Molecular Genetics & Genomic Medicine|December 22, 2017
Short report: Follow-up of Bahamian women with a BRCA1 or BRCA2 mutationSteven A Narod, Raleigh Butler, David Bobrowski, et al.
Journal of Global Oncology|July 19, 2017
Development of a Breast Cancer Treatment Program in Port-au-Prince, Haiti: Experiences From the FieldVincent DeGennaro, Rachel Libby, Elizabeth Patberg, et al.
Breast Cancer Research and Treatment|February 15, 2017
A high frequency of PALB2 mutations in Jamaican patients with breast cancerJordan Lerner-Ellis, Talia Donenberg, Humayun Ahmed, et al.
Clinical Breast Cancer|July 16, 2008
A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancerOrlando Silva, Gilberto Lopes, Daniel Morgenzstern, et al.
JAMA Network Open|December 5, 2023
Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIVDaniel S O'Neil, Yehoda M Martei, Katherine D Crew, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Pain education for underserved minority cancer patients: a randomized controlled trialKaren O Anderson, Tito R Mendoza, Richard Payne, et al.
Breast Cancer Research and Treatment|June 30, 2010
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancerChristopher Lobo, Gilberto Lopes, Odalys Baez, et al.
Lancet Regional Health. Americas|November 19, 2025
Differences in breast cancer outcomes amongst Caribbean born women in Florida, USA-a population-based analysisAlex P Sanchez-Covarrubias, Priscila Barreto-Coelho, Jovanka Ravix, et al.
Pageof 5